compounded glp-1 drugs from the Gray Market Compound versions of GLP-1 drugs
Description
Kelly MS, Scopelliti EM, Goodson KE, Cma L, Nguyen HX, Simon B
Results Nine RCTs involving 8920 patients with HF were included
If diarrhea occurs, ensure adequate hydration and electrolyte replacement
Erekat NS
I believe its a bit more complex than that
5 Together, SNAC-enabled peptide delivery and small-molecule agonists have the potential to expand access to incretin therapy by improving stability in the stomach, enhancing epithelial transport, and simplifying real-world use
